Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Toxin Alert was a Canadian biotechnology company that specialized in the development of diagnostic packaging materials designed to detect foodborne pathogens. The company's primary technology, Toxin Guard, utilized a polyethylene film embedded with specific antibodies that would provide a visual signal in the presence of bacteria such as E. coli, Salmonella, and Listeria. Headquartered in Mississauga, Ontario, the company aimed to revolutionize food safety by providing real-time contamination alerts directly on consumer packaging. Despite establishing partnerships with major packaging firms like Alcan, the company struggled with the high costs of commercial scaling and technical challenges. Toxin Alert is no longer active, having ceased its biotechnology operations in the mid-2000s.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Toxin Alert.